Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$805,410,876
-$1,286,928,939 QoQ
Shares Held
2,675,517
-57.7% QoQ
Ownership
2.00%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#10
of 780 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. ALNY ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $805,410,876 | 2,675,517 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $2,092,339,815 | 6,323,752 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $1,876,907,598 | 4,719,999 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $2,071,959,120 | 4,543,770 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $672,400,182 | 2,062,008 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $599,139,811 | 2,218,872 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $529,461,614 | 2,250,060 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $594,874,482 | 2,162,944 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $430,807,653 | 1,772,871 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $261,266,839 | 1,748,189 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $577,319,540 | 3,016,141 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $546,680,420 | 3,086,846 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $595,077,073 | 3,132,974 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $619,937,107 | 3,094,734 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $743,296,472 | 3,127,694 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $509,413,601 | 2,545,032 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $333,068,452 | 2,283,637 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $476,645,956 | 2,919,015 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $504,006,171 | 2,972,085 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $461,764,873 | 2,445,659 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $438,804,211 | 2,588,510 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $307,568,433 | 2,178,401 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $299,509,364 | 2,304,450 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $331,278,582 | 2,275,265 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $329,231,789 | 2,222,887 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $91,743,675 | 842,845 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||